Michele Goulart dos Santos

Michele Goulart dos Santos

Auto-generated profile, based on publicly available information

Michele Goulart dos Santos

Universidade Federal do Rio Grande

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 February 2022 in European Journal of Pharmacology
Verified
Journal Article
Closed access
BABruno Arbo
Bruno Arbo
LSLucia Emanueli Schimith
Lucia Emanueli Schimith
MSMichele Goulart dos Santos
Michele Goulart dos Santos
MHMariana Appel Hort
Mariana Appel Hort

9 May 2025 in Chemistry & Biodiversity
Verified
Journal Article
Open access
MSMichele Goulart dos Santos
Michele Goulart dos Santos
MDMarie Demonceaux
Marie Demonceaux
LSLucia Emanueli Schimith
Lucia Emanueli Schimith
MGMarine Goux
Marine Goux
CSClaude Solleux
Claude Solleux
MHMariana Appel Hort
Mariana Appel Hort
Quercetin (QUE) possesses various pharmacological properties; however, its low bioavailability and solubility hinder its beneficial effects. Enzymatic glycosylation has been explored to improve these aspects. In the present study, we used a sucrose phosphorylase variant to catalyze the regioselective transglucosylation of QUE, predicted the pharmacokinetic properties and toxicity of these molecules using in silico tools, and evaluated their cytotoxicity compared to the original molecule and a β‐glucosylated derivative of QUE. Three α‐glucosylated derivatives were obtained, which demonstrated improved pharmacokinetics, including a higher volume of distribution and lower clearance rate, with minimal likelihood of cytochrome P450 enzyme inhibition compared to QUE. QUE and the β‐glucosylated derivative exhibited cytotoxicity in both cell types evaluated, whereas their α‐glucosylated derivatives were nontoxic. The results presented provide an insight into the predicted behavior of these molecules in the body and, combined with cytotoxicity evaluation, will serve as a foundation for investigating the biological effects and mechanisms of action of these new molecules.

30 June 2025 in Revista Brasileira de Criminalística
Verified
Journal Article
Open access
PDF file
MSMichele Goulart dos Santos
Michele Goulart dos Santos
VVVinicius Vescovi
Vinicius Vescovi
RNRuthinéia Jéssica Alves Do Nascimento
Ruthinéia Jéssica Alves Do Nascimento
New psychoactive substances (NPS) are substances of abuse that have posed a significant threat in recent years. Accurate detection of NPS presents a major analytical challenge due to their structural diversity and their rapid emergence and disappearance from the market. In this context, given the wide structural variety of the different classes of NPS developed to circumvent legislation and the difficulties authorities face in detecting these compounds, the objective of this work was to perform a systematic review of the main analytical methods recently validated for the identification of NPS in biological matrices, as well as the primary sample preparation methods used in the detection process. The methodology followed the PRISMA-S guidelines, and studies were selected based on predefined inclusion and exclusion criteria. Ultimately, 74 studies were included in this review for data extraction. Blood was the most commonly analyzed biological matrix for the identification of NPS, and solid-phase extraction was the most frequently employed sample preparation method. Liquid chromatography, using a C18 column as the stationary phase and coupled with high-resolution mass spectrometry (LC-HRMS), emerged as the most commonly used analytical technique due to its high sensitivity and specificity in identifying NPS, with stimulants being the most prevalent class in the included studies. It is important to emphasize that there is no single ideal method for identifying NPS. A combination of different analytical tools may often be required to evaluate these substances, given their frequent structural modifications. This dynamic nature necessitates the continuous updating of detection methods by authorities.

31 August 2026 in Neurochemical Research
Verified
Journal Article
Open access
PDF file
DSdos Santos
dos Santos
MSMichele Dos Santos
Michele Dos Santos
TGTainá Guillante
Tainá Guillante
DAde Aguiar
de Aguiar
RFRafael Felipe
Rafael Felipe
MHMariana Appel Hort
Mariana Appel Hort
Neuroinflammation is a response of the central nervous system to injury, infection, or disease, involving the activation of glial cells and the release of cytokines and reactive species. When sustained or dysregulated, it contributes to the progression of neurological disorders. Quercetin (Que) is one of the most extensively studied flavonoids; however, its therapeutic application is limited by low bioavailability. Glucosylation has therefore emerged as a strategy to improve the physicochemical and biological properties of flavonoids. Previously, we synthesized the derivative quercetin-3’-α-D-glucoside (Que-3α) and characterized its pharmacokinetic profile and in vitro cytotoxicity. Here, we investigated the anti-inflammatory and antioxidant effects of Que and its derivatives, including the recently synthesized Que-3α and the naturally occurring β-glucoside, quercetin-3-β-D-glucoside (Que-3β), in a lipopolysaccharide (LPS)-induced inflammation model using C6 astroglial cells. Cells were pretreated for 2 h with the compounds (15 and 30 µM) and then stimulated with LPS (10 µg/mL) for 24 h. The compounds preserved mitochondrial activity, while Que and Que-3α reduced LPS-induced reactive oxygen species production, increased cell viability, and decreased apoptosis and necrosis. Notably, the Que-3α reduced iNOS expression, indicating more effective modulation of inflammatory mediators compared with the aglycone. These findings reinforce the biological properties of Que and suggest that α-glucosylation preserves the beneficial actions of Que while enhancing pharmacodynamic features relevant to neuroinflammation. Graphical Abstract

31 October 2026 in Neurochemical Research
Verified
Journal Article
Open access
PDF file
MCMilagros Fanny Vera Castro
Milagros Fanny Vera Castro
CACharles Elias Assmann
Charles Elias Assmann
BRBianca Vedoin Copês Rambo
Bianca Vedoin Copês Rambo
MSMairin Schott
Mairin Schott
MSMarcylene Vieira da Silveira
Marcylene Vieira da Silveira
MSMARIA ROSA CHITOLINA Schetinger
MARIA ROSA CHITOLINA Schetinger
High glucose-induced microglial activation contributes to inflammatory processes associated with diabetic complications. Thus, the effects of caffeic acid (CA) on inflammatory responses and purinergic signaling parameters in high glucose-challenged BV-2 microglial cells were investigated. A) Oxidative stress; b) Enzymatic activities of Ecto-nucleoside triphosphate diphosphohydrolase (E-NTPDase), Ecto-5-nucleotidase (E-5’-NT), and Adenosine deaminase (ADA); c) Density of P2X7R, A1R, and A2AR purinoceptors; d) Inflammatory markers (IBA-1, NLRP3, and IL-1β); and e) Apoptosis and cell cycle were assessed. Treatment with CA (50 and 75 µM, 24 h) in cells exposed to high glucose medium (GL 25 mM, 48 h) increased viability and reduced nitric oxide (NO), reactive species (RS), and thiobarbituric acid reactive substances (TBARS) levels compared to high glucose-challenged cells. CA also restored ATP and ADP hydrolysis and reduced ADA activity. Furthermore, CA increased the density of the A1R while reversing the high glucose-induced increase in P2X7R and A2AR densities. Moreover, CA treatment attenuated the increase in IL-1β density in high glucose medium, whereas only CA (75 µM) treatment reduced NLRP3 and IBA-1 densities. Besides, this phenolic compound decreased apoptosis and promoted cell cycle progression by increasing the proportion of cells in the S and G2/M phases. Overall, findings suggest that CA attenuates high glucose-induced inflammatory and oxidative alterations in BV-2 microglial cells, besides modulating purinergic enzyme activities and purinoceptor density. These results support the potential involvement of purinergic signaling in the cellular effects of CA and provide possible mechanistic insights into its antioxidant and anti-inflammatory actions under high glucose conditions.